Anti-Interleukin-12/23-Antikörper bei Colitis ulcerosa

被引：0
|
作者：
Manfred Gross
机构：
[1] Internistische Klinik München Süd,
来源：
Gastro-News | 2020年 / 7卷 / 2期
关键词：
D O I：
10.1007/s15036-020-0275-3
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：18 / 21
页数：3
相关论文
共 50 条
  • [21] Anti-interleukin-12 antibody - Potential role in preventing relapses of multiple sclerosis
    Fox, RJ
    Rostami, AM
    BIODRUGS, 2000, 13 (04) : 233 - 241
  • [22] Selektiver IL23-Inhibitor mit guter Wirkung bei Morbus Crohn und Colitis ulcerosa
    Wiebke Kathmann
    Gastro-News, 2022, 9 (3) : 60 - 60
  • [23] Anti-interleukin-12/23p40 antibody attenuates chronic rejection of cardiac allografts partly via inhibition ?dT cells
    Wang, S.
    Xu, X.
    Xie, A.
    Li, J.
    Ye, P.
    Liu, Z.
    Wu, J.
    Rui, L.
    Xia, J.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2012, 169 (03): : 320 - 329
  • [24] Juveniler Morbus Adamantiades-Behçet bei erniedrigter Stimulation mit Anti-CD3-monoklonalen Antikörper
    Katja Krüger
    Klaus Fritz
    Volker Daniel
    Christos C. Zouboulis
    Der Hautarzt, 1997, 48 : 258 - 261
  • [25] Anti-interleukin-23 agents for the treatment of ulcerative colitis
    Hanzel, Jurij
    D'Haens, Geert R.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2020, 20 (04) : 399 - 406
  • [26] Myocardial Infarction in a Patient Treated with Anti-Interleukin-12 Biological Agent for Chronic Plaque Psoriasis
    Stinco, Giuseppe
    Buligan, Cinzia
    Bergamo, Serena
    Morgante, Olvino
    Iacono, Maria Antonietta
    Patrone, Pasquale
    ANNALS OF DERMATOLOGY, 2014, 26 (01) : 137 - 138
  • [27] Treatment with anti-interleukin-12 monoclonal antibody alleviates acute rejection of mouse islet allografts.
    Wada, Y
    Arai, K
    Sunamura, M
    Kobari, M
    Matsuno, S
    GASTROENTEROLOGY, 1998, 114 (04) : A1433 - A1433
  • [28] Anti-interleukin-12 antibody for active Crohn's disease (vol 351, pg 2069, 2004)
    不详
    NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (12): : 1276 - 1276
  • [29] Functional characterization of SMARTTM humanized anti-interleukin-12 monoclonal antibody, HAIL-12, in humans and cynomolgus monkeys.
    Zhao, V
    Li, J
    Woo, J
    McClellan, M
    Keller, S
    Gemmel, L
    Landolfi, N
    Bullock, C
    Vexler, V
    CLINICAL IMMUNOLOGY, 2002, 103 (03) : S49 - S49
  • [30] Combination of antitumour necrosis factor-α and anti-interleukin-12/23 antibodies in refractory psoriasis and psoriatic arthritis: a long-term case-series observational study
    Gniadecki, R.
    Bang, B.
    Sand, C.
    BRITISH JOURNAL OF DERMATOLOGY, 2016, 174 (05) : 1145 - 1146
12345